Related references
Note: Only part of the references are listed.Glioblastoma Extracellular Vesicle-Specific Peptides Inhibit EV-Induced Neuronal Cytotoxicity
Wenbo Zhou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2021)
Extracellular Vesicle-Mediated Bilateral Communication between Glioblastoma and Astrocytes
Lisa Nieland et al.
TRENDS IN NEUROSCIENCES (2021)
An appraisal of antigen identification and IgG effector functions driving host immune responses in multiple sclerosis
Xiaoli Yu et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma
Kenji Fujimoto et al.
ACTA NEUROPATHOLOGICA (2021)
The Interplay between Glioblastoma and Its Microenvironment
Mark Dapash et al.
CELLS (2021)
Circulating biomarkers in patients with glioblastoma
Juliana Muller Bark et al.
BRITISH JOURNAL OF CANCER (2020)
The biology, function, and biomedical applications of exosomes
Raghu Kalluri et al.
SCIENCE (2020)
Novel Therapies for Glioblastoma
Elisa K. Liu et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2020)
Targeting and Crossing the Blood-Brain Barrier with Extracellular Vesicles
Julien Saint-Pol et al.
CELLS (2020)
Molecular Heterogeneity and Immunosuppressive Microenvironment in Glioblastoma
Syreeta DeCordova et al.
FRONTIERS IN IMMUNOLOGY (2020)
Longer-term (≥2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis
Michael T. C. Poon et al.
SCIENTIFIC REPORTS (2020)
The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy
Fiona A. Desland et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Basis for Immunotherapy for Treatment of Meningiomas
Tomas Garzon-Muvdi et al.
FRONTIERS IN NEUROLOGY (2020)
Meningioma: A Review of Clinicopathological and Molecular Aspects
Kristin Huntoon et al.
FRONTIERS IN ONCOLOGY (2020)
Brain Tumor Microenvironment and Host State: Implications for Immunotherapy
William Tomaszewski et al.
CLINICAL CANCER RESEARCH (2019)
Roles of Extracellular Vesicles in High-Grade Gliomas: Tiny Particles with Outsized Influence
Michael W. Graner
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 20, 2019 (2019)
Exosomes
D. Michiel Pegtel et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 88 (2019)
The Role of Checkpoint Inhibitors in Glioblastoma
Kunal Desai et al.
TARGETED ONCOLOGY (2019)
Human umbilical cord mesenchymal stem cells derived-exosomes in diseases treatment
Yoda Yaghoubi et al.
LIFE SCIENCES (2019)
Molecular targeted therapy of glioblastoma
Emilie Le Rhun et al.
CANCER TREATMENT REVIEWS (2019)
Potential of Exosomes for the Treatment of Stroke
Shi-Bin Hong et al.
CELL TRANSPLANTATION (2019)
Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity
Michela Capello et al.
NATURE COMMUNICATIONS (2019)
Glioblastoma cells vampirize WNT from neurons and trigger a JNK/MMP signaling loop that enhances glioblastoma progression and neurodegeneration
Marta Portela et al.
PLOS BIOLOGY (2019)
Glioblastoma multiforme-derived extracellular vesicles drive normal astrocytes towards a tumour-enhancing phenotype
Soliman Oushy et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2018)
Advances in meningioma genetics: novel therapeutic opportunities
Matthias Preusser et al.
NATURE REVIEWS NEUROLOGY (2018)
Meningioma: The Tumor That Taught Us Neurosurgery
Devi Prasad Patra et al.
WORLD NEUROSURGERY (2018)
Extracellular vesicles in cancer immune responses: roles of purinergic receptors
Michael W. Graner
SEMINARS IN IMMUNOPATHOLOGY (2018)
Immunotherapy in Glioblastoma
Jessica A. Wilcox et al.
WORLD NEUROSURGERY (2018)
Extracellular Vesicles: Unique Intercellular Delivery Vehicles
Sybren L. N. Maas et al.
TRENDS IN CELL BIOLOGY (2017)
Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma
Julia Tichy et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Glioma-derived extracellular vesicles selectively suppress immune responses
Justin E. Hellwinkel et al.
NEURO-ONCOLOGY (2016)
Characterization of Differentiated SH-SY5Y as Neuronal Screening Model Reveals Increased Oxidative Vulnerability
J. I. Forster et al.
JOURNAL OF BIOMOLECULAR SCREENING (2016)
Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma
N-s Lai et al.
BRITISH JOURNAL OF CANCER (2015)
Plasma miR-185 as a predictive biomarker for prognosis of malignant glioma
Hailin Tang et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2015)
Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity
Isaak Quast et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival
Aida Kiviniemi et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
miRNA microarray reveals specific expression in the peripheral blood of glioblastoma patients
Lun Dong et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Exosomes: Looking back three decades and into the future
Clifford V. Harding et al.
JOURNAL OF CELL BIOLOGY (2013)
Molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies
K. Masui et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2012)
EGFRvIII-Targeted Vaccination Therapy of Malignant Glioma
Bryan D. Choi et al.
BRAIN PATHOLOGY (2009)
Serum GFAP is a diagnostic marker for glioblastoma multiforme
C. S. Jung et al.
BRAIN (2007)
Convergent solutions to binding at a protein-protein interface
WL DeLano et al.
SCIENCE (2000)
Share Paper
